As of 2024-09-09, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (2.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.02 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -147.9%.
The range of the Relative Valuation is (5.72) - 2.78 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 51.4x | 37.0x |
| Forward P/E multiples | 21.8x - 29.1x | 22.2x |
| Fair Price | (5.72) - 2.78 | (2.41) |
| Upside | -213.9% - -44.6% | -147.9% |
| Date | P/E |
| 2024-09-06 | -26.79 |
| 2024-09-05 | -27.11 |
| 2024-09-04 | -27.11 |
| 2024-09-03 | -27.11 |
| 2024-08-30 | -28.23 |
| 2024-08-29 | -27.85 |
| 2024-08-28 | -28.12 |
| 2024-08-27 | -28.55 |
| 2024-08-26 | -29.29 |
| 2024-08-23 | -29.13 |
| 2024-08-22 | -28.28 |
| 2024-08-21 | -28.81 |
| 2024-08-20 | -28.17 |
| 2024-08-19 | -28.55 |
| 2024-08-16 | -27.75 |
| 2024-08-15 | -27.59 |
| 2024-08-14 | -27.32 |
| 2024-08-13 | -27.27 |
| 2024-08-12 | -27.37 |
| 2024-08-09 | -27.69 |
| 2024-08-08 | -28.33 |
| 2024-08-07 | -27.75 |
| 2024-08-06 | -28.33 |
| 2024-08-05 | -28.33 |
| 2024-08-02 | -28.81 |
| 2024-08-01 | -30.09 |
| 2024-07-31 | -31.16 |
| 2024-07-30 | -31.16 |
| 2024-07-29 | -32.02 |
| 2024-07-26 | -32.98 |
| 2024-07-25 | -32.82 |
| 2024-07-24 | -32.92 |
| 2024-07-23 | -33.62 |
| 2024-07-22 | -33.83 |
| 2024-07-19 | -32.60 |
| 2024-07-18 | -32.39 |
| 2024-07-17 | -33.19 |
| 2024-07-16 | -33.24 |
| 2024-07-15 | -32.12 |
| 2024-07-12 | -31.59 |
| 2024-07-11 | -30.95 |
| 2024-07-10 | -27.80 |
| 2024-07-09 | -28.39 |
| 2024-07-08 | -28.12 |
| 2024-07-05 | -27.96 |
| 2024-07-03 | -28.60 |
| 2024-07-02 | -28.12 |
| 2024-07-01 | -29.77 |
| 2024-06-28 | -30.15 |
| 2024-06-27 | -31.00 |